Cargando…
Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study
BACKGROUND: To investigate the efficacy and safety of a combined oral contraceptive containing estradiol valerate and dienogest (EV/DNG) in healthy Asian women. METHODS: In this multicenter Phase III study, women received oral EV/DNG in a 28-day regimen for 13 cycles. The primary efficacy endpoint w...
Autores principales: | Yu, Qi, Huang, Zirong, Ren, Mulan, Chang, Qing, Zhang, Zhongqi, Parke, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995293/ https://www.ncbi.nlm.nih.gov/pubmed/29922096 http://dx.doi.org/10.2147/IJWH.S157056 |
Ejemplares similares
-
Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest
por: Bitzer, Johannes, et al.
Publicado: (2011) -
Contraception with estradiol valerate and dienogest: adherence to the method
por: Fruzzetti, Franca, et al.
Publicado: (2019) -
Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive: An Open-Label, Randomized, Crossover Study of Estradiol Valerate/Dienogest versus Ethinylestradiol/Levonorgestrel
por: Klipping, Christine, et al.
Publicado: (2012) -
Estradiol valerate and dienogest: a new approach to oral contraception
por: Kiley, Jessica W, et al.
Publicado: (2011) -
Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest
por: Rafie, Sally, et al.
Publicado: (2013)